Included in the deal are the following products and tools:
• The SonaStar is used by neurosurgeons and general surgeons for quick and efficient removal of hard and soft tumors while sparing most vessels and other surrounding tissue. It is engineered to provide powerful and precise ultrasonic aspiration with maximum control and ease-of-use.
• The BoneScalpel is a novel tissue-specific osteotomy device capable of safely making precise cuts through bone and hard tissue. It is designed to provide clean cuts through osseous structures with minimal loss of viable bone while sparing adjacent soft tissues.
• OsteoSculpt bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site. The product is used by neurosurgeons, cranio-maxillofacial surgeons, and orthopedic surgeons for a wide range of procedures.
“We are quite pleased to add Soelim to our distribution organization in Asia; they represent a large and growing medical market and their presence should add measurably to our sales success. Their reputation for successfully introducing new products into the South Korean market is second to none,” said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. “We are particularly pleased that they will be selling two of our key products to the South Korean market.”
Misonix is a surgical device company that designs, manufactures, and markets innovative therapeutic ultrasonic products worldwide for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications.
To learn more about the company, visit www.Misonix.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
